Literature DB >> 10861779

Modelling covariance structure in the analysis of repeated measures data.

R C Littell1, J Pendergast, R Natarajan.   

Abstract

The term 'repeated measures' refers to data with multiple observations on the same sampling unit. In most cases, the multiple observations are taken over time, but they could be over space. It is usually plausible to assume that observations on the same unit are correlated. Hence, statistical analysis of repeated measures data must address the issue of covariation between measures on the same unit. Until recently, analysis techniques available in computer software only offered the user limited and inadequate choices. One choice was to ignore covariance structure and make invalid assumptions. Another was to avoid the covariance structure issue by analysing transformed data or making adjustments to otherwise inadequate analyses. Ignoring covariance structure may result in erroneous inference, and avoiding it may result in inefficient inference. Recently available mixed model methodology permits the covariance structure to be incorporated into the statistical model. The MIXED procedure of the SAS((R)) System provides a rich selection of covariance structures through the RANDOM and REPEATED statements. Modelling the covariance structure is a major hurdle in the use of PROC MIXED. However, once the covariance structure is modelled, inference about fixed effects proceeds essentially as when using PROC GLM. An example from the pharmaceutical industry is used to illustrate how to choose a covariance structure. The example also illustrates the effects of choice of covariance structure on tests and estimates of fixed effects. In many situations, estimates of linear combinations are invariant with respect to covariance structure, yet standard errors of the estimates may still depend on the covariance structure. Copyright 2000 John Wiley & Sons, Ltd.

Mesh:

Year:  2000        PMID: 10861779     DOI: 10.1002/1097-0258(20000715)19:13<1793::aid-sim482>3.0.co;2-q

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  163 in total

1.  Treatment outcomes in type A and B alcohol dependence 6 months after serotonergic pharmacotherapy.

Authors:  William Dundon; Kevin G Lynch; Helen M Pettinati; Craig Lipkin
Journal:  Alcohol Clin Exp Res       Date:  2004-07       Impact factor: 3.455

2.  Primary care, infant mortality, and low birth weight in the states of the USA.

Authors:  L Shi; J Macinko; B Starfield; J Xu; J Regan; R Politzer; J Wulu
Journal:  J Epidemiol Community Health       Date:  2004-05       Impact factor: 3.710

3.  Curve-based multivariate distance matrix regression analysis: application to genetic association analyses involving repeated measures.

Authors:  Rany M Salem; Daniel T O'Connor; Nicholas J Schork
Journal:  Physiol Genomics       Date:  2010-04-27       Impact factor: 3.107

4.  Smokeless tobacco reduction with the nicotine lozenge and behavioral intervention.

Authors:  Jon O Ebbert; Amanda Edmonds; Xianghua Luo; Joni Jensen; Dorothy K Hatsukami
Journal:  Nicotine Tob Res       Date:  2010-06-04       Impact factor: 4.244

5.  Assessment of drowsiness based on ocular parameters detected by infrared reflectance oculography.

Authors:  Clare Anderson; Anne-Marie Chang; Jason P Sullivan; Joseph M Ronda; Charles A Czeisler
Journal:  J Clin Sleep Med       Date:  2013-09-15       Impact factor: 4.062

Review 6.  Identification of determinants of exposure: consequences for measurement and control strategies.

Authors:  A Burdorf
Journal:  Occup Environ Med       Date:  2005-05       Impact factor: 4.402

7.  Effects of Restricted Time in Bed on Antidepressant Treatment Response: A Randomized Controlled Trial.

Authors:  J Todd Arnedt; Leslie M Swanson; Richard R Dopp; Holli S Bertram; Ann J Mooney; Edward D Huntley; Robert F Hoffmann; Roseanne Armitage
Journal:  J Clin Psychiatry       Date:  2016-10       Impact factor: 4.384

8.  Short-term hypoxia reduces arterial stiffness in healthy men.

Authors:  Hima Vedam; Craig L Phillips; David Wang; David J Barnes; Jan A Hedner; Gunnar Unger; Ronald R Grunstein
Journal:  Eur J Appl Physiol       Date:  2008-09-25       Impact factor: 3.078

9.  Patient and practice impact of capecitabine compared to taxanes in first-/second-line chemotherapy for metastatic breast cancer.

Authors:  Lee S Schwartzberg; Patrick Cobb; Mark S Walker; Edward J Stepanski; Arthur C Houts
Journal:  Support Care Cancer       Date:  2009-01-13       Impact factor: 3.603

10.  Randomized controlled trial of telephone-delivered cognitive behavioral therapy for chronic insomnia.

Authors:  J Todd Arnedt; Leisha Cuddihy; Leslie M Swanson; Scott Pickett; James Aikens; Ronald D Chervin
Journal:  Sleep       Date:  2013-03-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.